GDM Screening During COVID Pandemic. IADPSG vs WHO '99 Criteria
NCT ID: NCT05026840
Last Updated: 2022-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2020-03-01
2021-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These data will be compared between the 2 groups consisting in those diagnosed with only IADPSG criteria versus those diagnosed with only WHO '99 criteria.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
NCT06109597
Gestational Diabetes: a Cohort Study
NCT03307486
Screening For First Trimester's Hyperglycemia in High and Low Risk Pregnancy
NCT06064552
Early Screen and Treatment for Gestational Diabetes
NCT02377531
Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus
NCT05487352
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IADPSG
GDM screening criteria
difference in risk factors and clinical outcomes between groups
WHO '99
GDM screening criteria
difference in risk factors and clinical outcomes between groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GDM screening criteria
difference in risk factors and clinical outcomes between groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Messina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rosario D'anna
full professor of obstetrics and gynecology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Messina, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
van-de-l'Isle Y, Steer PJ, Watt Coote I, Cauldwell M. Impact of changes to national UK Guidance on testing for gestational diabetes screening during a pandemic: a single-centre observational study. BJOG. 2021 Apr;128(5):917-920. doi: 10.1111/1471-0528.16482. Epub 2020 Oct 7.
D'Anna R, Di Benedetto A, Palella S, Miceli A, Romeo P, Corrado F. Screening of GDM during COVID pandemic in an Italian setting: comparison between IADPSG and WHO '99 criteria. Diabetol Metab Syndr. 2022 Oct 31;14(1):164. doi: 10.1186/s13098-022-00936-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IADPSG vs WHO '99
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.